Merck & Co.‚ Inc (A) (The summary is based on the article in Vol. I and does not include the extra readings given by the professor) This case is a classic example of enterprises trying to balance their business of increasing profits and expected social responsibilities. This dilemma is further accentuated when the company happens to be a pharma company whose decisions directly affect people’s lives. The Dilemma: A possible drug for River Blindness‚ a disease which affects almost 85 million
Premium Pharmacology Medicine Affect
Merck and Co. and river blindness MANUEL VELASQUEZ‚ Business Ethics. Concepts and cases 4th edt.‚ Prentice Hall‚ Upper Saddle River‚ New Jersey‚ 1998 River blindness is an agonizing disease that affects some 18 million impoverished people living in remote villages along the banks of rivers in tropical regions of Africa and Latin America. The disease is caused by a tiny parasitic worm that is passed from person to person by the bite of the black fly which breeds in river waters. The tiny worms
Premium Pharmaceutical industry Ethics Drug discovery
BUAD820 – Case 2 Merck Case Decision Tree and Analysis Presented By – Sridevi Chennuri Nuray Coban Subhashini Reddy Merck & Company :Evaluating a Drug Licensing Opportunity • Background - Merck & Company : •In 2000‚ it was a global research-driven pharmaceutical company that discovers‚ develop‚ manufactures and markets a broad range of human and animal health products‚ directly and through its joint ventures‚ and provides pharmaceutical benefit management services through Merck-Medco Managed Care
Premium Clinical trial Decision tree Expected value
Case #1: Merck and River Blindness MGT 597: Leadership Ethics Dr. Brandon Randolph-Seng Javiaur Harmon: Winter Mini 2014 - 2015 1. Think about the definition stakeholders—any parties with a stake in the organization’s actions or performance. Who are the stakeholders in this situation? How many can you list? On what basis would you rank them in importance? The stakeholders in this situation were the employees (research scientists doing the R&D)‚ Merck‚ and the target audience which
Premium Value system Risk Intrinsic value
Merck‚ being on one of the biggest pharmaceutical companies in the world today‚ came from a meek beginning and still encounters many problems today while trying to maintain a lead amongst its competition. While being looked at as a research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. Attracting talent to work for the company has never been a problem for Merck‚ but the bigger question was whether or not this talent would be able
Premium Pharmaceutical industry Pharmacology Generic drug
As a result of worldwide withdrawal of Vioxx‚ Merck faced a serious public relations crisis in the fall of 2004. Pharmaceutical giant’s officials were forced to defend company’s actions‚ its motivation for those actions‚ and its reputation after several articles‚ negatively reflecting on Merck’s behavior handling the Vioxx case‚ had been published. As an initial response to Vioxx crisis‚ the company released “An Open Letter from Merck” and “For 100 years‚ patients first” in attempt at a positive
Premium Pharmacology Pharmaceutical drug Drug
Merck and River Blindness (Onchocerciasis) In understanding the decision Merck made to donate medicines‚ we need to start by understanding the motivations and core values behind the company that undertook the actions. We can get some insight into these by examining and understanding their company mission statement: The mission of Merck is to provide society with superior products and services‚ innovations‚ and solutions that improve the quality of life and satisfy customer needs-to provide employees
Premium Water Water pollution Kidney
CEO Ray Gilmartin Merck’s CEO Ray Gilmartin is a significant stakeholder in the company. Since a lot of Mercks’ products patents will be expiring in the next few years Gilmartin put a big emphasis on investing into the companies research and development of new products. Gilmartin wanted this company to really focus on coming out with new products because their bottom line was going to take a hit in the next few years once the patent on their big money products runs out. Gilmartin found it an
Premium Pharmacology Finance Management occupations
Business and Professional Ethics MERCK AND THE MARKETING OF VIOXX – CASE ANALYSIS Questions 1) What are the highlights of the case? 2) What are the ethical issues in the case? 3) What the ethical theories evidenced in the case? 4) How would you resolve the problem? What are the ethical issues in the case? In identifying the issue(s) we first have to identify the level in which this business is operating. Merck & Company was a top‚ well respected pharmaceutical company in America
Premium Ethics
2011). In 1978‚ Merck‚ while testing invermectin (a parasite killing drug for animals)‚ found that invermectin killed a parasite similar to the one that caused river blindness. The problem for Merck was that river blindness generally only affects people in very poor areas and there was very little chance to recoup their financial investment by selling the drug. The ethical dilemma represented by this situation is focused on what course of action Merck should take. Does Merck invest precious resources
Premium Ethics Decision making Onchocerciasis